临床试验支持服务市场基础(关键地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029938
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市场概览

临床试验支持服务对于制药公司在新药试验过程或仿制药和生物类似药的分子分析过程中至关重要。它们对于药物开发、分析设计和临床测试至关重要。这些服务对于药物成功推向市场非常有利。为临床前研究和研究提供临床试验支持服务,包括临床现场协助、获取和存储研究药物、盲法研究药物、患者招募、协调和核对退回的药品。

< p>“2031 年全球临床试验支持服务市场分析”是对医疗器械行业的专业和深入研究,特别注重全球市场趋势分析。该报告旨在概述临床试验支持服务市场,并按服务、阶段、申办者和地理位置进行详细的市场细分。该报告提供了领先的临床试验支持服务市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

市场驱动因素

推动临床试验支持服务市场增长的因素包括制药和生物制药企业研发支出的增加、慢性病和慢性病患病率的增加疾病爆发以及新兴市场进行临床试验的需要。但是,患者入组的监管要求以及开源和免费软件的可用性。

慢性病和慢性病的患病率不断增加疾病爆发正在推动市场增长。与健康相关的问题增多是由环境和人们生活方式的变化引起的。一系列慢性疾病和病症影响着老年人口。阿尔茨海默病和其他痴呆症、关节炎、癌症、糖尿病、心脏病、肥胖症、骨质疏松症、烟草相关疾病、肠易激综合症和其他问题在普通人群中变得更加普遍和明显。 1918年,西班牙流感在全球范围内暴发了两年。 COVID-19 于 2021 年开始在世界范围内传播,并持续发展。自2022年以来,猴痘病毒一直是欧洲和北美爆发疫情的原因。例如,加拿大关节炎社区研究和评估单位ACREU进行的一项调查发现,20岁以上的加拿大人中约有15%患有骨关节炎。报告指出,加拿大有超过400万人患有骨关节炎,约每7个成年人中就有1人患有骨关节炎。因此,慢性病和慢性疾病的患病率不断增加。疾病爆发正在推动临床试验支持服务市场的增长。

全球细分分析

全球临床试验支持服务市场分为服务、阶段和赞助商。服务部分细分为临床试验现场管理、患者招募管理、数据管理、行政人员、IRB 等。此外,患者招募管理分为患者招募和患者招募管理。登记服务、患者保留等。根据阶段,市场分为第一阶段、第二阶段、第三阶段和第四阶段。根据赞助商,市场分为制药和制药。生物制药、医疗器械等。

基于阶段,阶段III 细分市场主导了临床试验支持服务市场份额。由于样本量较小,该阶段的失败率最高,并且研究设计通常需要以最佳剂量进行复杂的给药。失败会导致人员和财务损失,其中很大一部分失败是由于未能达到安全或功效标准而造成的。参与 III 期试验的成本和受试者数量的增加是该细分市场增长的主要原因。由于该阶段的特点是样本量小,并且研究设计往往需要以最佳值进行复杂的给药,因此失败率最高。失败会导致人员和财务损失,大部分是由于不遵守安全和功效标准造成的。因此,III期细分市场推动了临床试验支持服务市场的增长。

报告提供行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的临床试验支持服务市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲非洲 (MEA) 和南美洲中美洲。每个地区的临床试验支持服务市场随后按各自的国家和细分市场进行细分。报告涵盖了全球18个国家的分析和预测以及该地区当前的趋势和机遇。

报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还对所有五个地区进行了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲在评估影响这些地区临床试验支持服务市场的政治、经济、社会和技术因素后,我们对中美洲进行了评估。

2022年,北美在全球临床试验支持服务市场份额中占据最大份额。美国大多数制药公司在该地区经营大量业务。鉴于该领域进行了大量临床研究,该市场可能会增长。研发方面的大量投资以及政府对临床试验的支持也支持了市场的增长。北美市场的增长得到了大型合同研究组织的支持,这些组织为临床试验和国际制药及临床试验提供支持服务。生物技术公司大力投资此类研究。

市场玩家

该报告涵盖了临床试验的主要进展支持服务市场作为有机和无机增长战略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略活动包括收购、合作伙伴关系和合作伙伴关系。合作。这些活动为扩大市场参与者的业务和客户群铺平了道路。随着全球市场对临床试验支持服务的需求不断增长,预计临床试验支持服务市场的市场支付者未来将获得利润丰厚的增长机会。

该报告还包括临床试验支持服务市场中主要公司的概况及其 SWOT 分析和市场策略。此外,该报告重点关注行业领先企业,提供公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。

  • 查尔斯河实验室国际有限公司
  • ICON PLC
  • PAREXEL INTERNATIONAL CORPORATION
  • NOVO NORDISK AS
  • IQVIA HOLDINGS INC.
  • 无锡安普泰
  • Thermo FISHER SCIENTIFIC
  • ALMAC
  • UDG HEALTHCARE PLC。
  • 塞维利亚临床用品服务 PVT 有限公司

近期进展

  • 2022 年 1 月,Charles River Laboratories International Inc. 扩大了与 SAMDI Tech Inc. 的合资企业,通过自组装单层膜和 MALDI 相结合,解决与传统质谱筛选方法相关的通量和样品制备限制MS.
  • 2023 年 3 月,诺和诺德今天宣布了 PIONEER PLUS 试验的主要结果,这是一项 3b 期、为期 68 周的疗效和安全性试验,每日一次口服索马鲁肽 25 毫克和 50 毫克与 14 毫克毫克作为需要强化治疗的 2 型糖尿病患者稳定剂量的 1-3 种口服抗糖尿病药物的补充。使用 25 毫克或 50 毫克剂量的索马鲁肽,本研究实现了其主要目标与口服 14 毫克索马鲁肽相比,52 周时 HbA1c 显着降低,从而达到终点。
  • 2021年4月,药明康德收购了临床研究服务公司Pharmapace, Inc.,以通过数据管理、统计编程、数据集成、生物统计和医学写作来扩展其在临床研究领域的生物识别产品。

Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the future trend for the market

Development of safe and durable implants is likely to remain key trends in the market

What is the opportunity for clinical trials support services market?

Emerging nations are likely to create growth opportinities for the market

What are the driving factors impacting the anti-infective agents market

The market drivers include growing emphasis on physical appearance and growing elder population

Which region dominated the clinical trials support services market in 2023?

North America dominated the cosmetic implants market in 2023

What is the expected CAGR of the Clinical Trials Support Services Market?

The Clinical Trials Support Services Market is estimated to witness a CAGR of 7.50% from 2023 to 2031

Which region is expected to witness fastest growth rate?

Asia-Pacific is expected to witness fastest growth rate.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies
1. CHARLES RIVER LABORATORIES INTERNATIONAL INC
2. ICON PLC
3. PAREXEL INTERNATIONAL CORPORATION
4. NOVO NORDISK AS
5. IQVIA HOLDINGS INC.
6. WUXI APPTEC
7. THERMO FISHER SCIENTIFIC
8. ALMAC
9. UDG HEALTHCARE PLC.
10. SEVEILLAR CLINICAL SUPPLIES SERVICES PVT LTD



Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.